Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels

被引:125
作者
Murdoch, Hannah
Mackie, Shaun
Collins, Daniel M.
Hill, Elaine V.
Bolger, Graeme B.
Klussmann, Enno
Porteous, David J.
Millar, J. Kirsty
Houslay, Miles D.
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Edinburgh, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Leibniz Molekulare Pharmakol, D-13125 Berlin, Germany
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
基金
英国医学研究理事会;
关键词
cAMP; phosphodiesterase-4; PDE4; DISC1; rolipram; scaffold proteins;
D O I
10.1523/JNEUROSCI.1493-07.2007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Disrupted-in-schizophrenia 1 ( DISC1) is a genetic susceptibility factor for schizophrenia and related severe psychiatric conditions. DISC1 is a multifunctional scaffold protein that is able to interact with several proteins, including the independently identified schizophrenia risk factor phosphodiesterase-4B ( PDE4B). Here we report that the 100 kDa full-length DISC1 isoform ( fl-DISC1) can bind members of each of the four gene, cAMP-specific PDE4 family. Elevation of intracellular cAMP levels, so as to activate protein kinase A, caused the release of PDE4D3 and PDE4C2 isoforms from fl-DISC1 while not affecting binding of PDE4B1 and PDE4A5 isoforms. Using a peptide array strategy, we show that PDE4D3 binds fl-DISC1 through two regions found in common with PDE4B isoforms, the interaction of which is supplemented because of the presence of additional PDE4B-specific binding sites. We propose that the additional binding sites found in PDE4B1 underpin its resistance to release during cAMP elevation. We identify, for the first time, a functional distinction between the 100 kDa long DISC1 isoform and the short 71 kDa isoform. Thus, changes in the expression pattern of DISC1 and PDE4 isoforms offers a means to reprogram their interaction and to determine whether the PDE4 sequestered by DISC1 is released after cAMP elevation. The PDE4B-specific binding sites encompass point mutations in mouse Disc1 that confer phenotypes related to schizophrenia and depression and that affect binding to PDE4B. Thus, genetic variation in DISC1 and PDE4 that influence either isoform expression or docking site functioning may directly affect psychopathology.
引用
收藏
页码:9513 / 9524
页数:12
相关论文
共 68 条
[1]   Protein kinase A as a therapeutic target for memory disorders: rationale and challenges [J].
Arnsten, AFT ;
Ramos, BP ;
Birnbaum, SG ;
Taylor, JR .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (03) :121-128
[2]   Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of β-arrestin using spot-immobilized peptide arrays [J].
Baillie, George S. ;
Adams, David R. ;
Bhari, Narinder ;
Houslay, Thomas M. ;
Vadrevu, Suryakiran ;
Meng, Dong ;
Li, Xiang ;
Dunlop, Allan ;
Milligan, Graeme ;
Bolger, Graeme B. ;
Klussmann, Enno ;
Houslay, Miles D. .
BIOCHEMICAL JOURNAL, 2007, 404 (71-80) :71-80
[3]   Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract [J].
Baillie, GS ;
Scott, JD ;
Houslay, MD .
FEBS LETTERS, 2005, 579 (15) :3264-3270
[4]   TAPAS-1, a novel microdomaln within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid [J].
Baillie, GS ;
Huston, E ;
Scotland, G ;
Hodgkin, M ;
Gall, I ;
Peden, AH ;
MacKenzie, C ;
Houslay, ES ;
Currie, R ;
Pettitt, TR ;
Walmsley, AR ;
Wakelam, MJO ;
Warwicker, J ;
Houslay, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) :28298-28309
[5]   Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory [J].
Barad, M ;
Bourtchouladze, R ;
Winder, DG ;
Golan, H ;
Kandel, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :15020-15025
[6]  
Bardsley M J, 1992, Qual Health Care, V1, P10, DOI 10.1136/qshc.1.1.10
[7]   UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions [J].
Beard, MB ;
Olsen, AE ;
Jones, RE ;
Erdogan, S ;
Houslay, MD ;
Bolger, GB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10349-10358
[8]   Improving memory: A role for phosphodiesterases [J].
Blokland, A. ;
Schreiber, R. ;
Prickaerts, J. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) :2511-2523
[9]  
Bolger GB, 1997, BIOCHEM J, V328, P539
[10]   Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, β-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5 [J].
Bolger, Graeme B. ;
Baillie, George S. ;
Li, Xiang ;
Lynch, Martin J. ;
Herzyk, Pawel ;
Mohamed, Ahmed ;
Mitchell, Lisa High ;
McCahill, Angela ;
Hundsrucker, Christian ;
Klussmann, Enno ;
Adams, David R. ;
Houslay, Miles D. .
BIOCHEMICAL JOURNAL, 2006, 398 (01) :23-36